Aerovate Therapeutics, Inc. (AVTE) Weighted Average Number of Shares Outstanding, Basic 2021 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aerovate Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2021 to 2024.
  • Aerovate Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 27.8 M shares, a 12.2% increase year-over-year.
  • Aerovate Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 26.3 M shares, a 7.6% increase from 2022.
  • Aerovate Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 24.5 M shares, a 99.1% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 27.8 M +3.02 M +12.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 26.3 M +1.86 M +7.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 27.6 M +3.19 M +13% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 25.2 M +756 K +3.1% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 24.8 M +367 K +1.51% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 24.5 M +12.2 M +99.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 24.5 M +570 K +2.39% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 24.4 M +24.2 M +9942% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 24.4 M +24.2 M +9942% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 12.3 M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-29
Q3 2021 23.9 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 243 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 243 K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.